In breast cancer, the most expressed sialyltransferase was ST3Gal III which positively correlated to tumour size and the number of axilary nodes; and moreover high ST3Gal III/ST6Gal I ratio was correlated with a shorter overall survival and bad prognosis [8], [9]. Here, ST3GAL3 is linked to neoplasm.